NutraNomics (NNRX) Provides Detailed Shareholder Update

Salt Lake City, UT. --  September 10, 2018 -- Investorshub NewsWire -- NutraNomics, Inc. formerly DBA Health Education Corp. (USOTC:NNRX) has a long and dedicated history as an industry leader in the nutraceutical and overall wellness markets. We are a significant contributor in these markets through internal and third party partner scientific research, as well as innovation in product development within the nutraceutical market. First and foremost, we focus on clinically-proven formulas with applications in nutritional supplements, personal care, and post treatment therapy. 

Over the last year and a half, the organization has restructured its financial position and strategies. The revamp has brought a marketing focus with innovation that is a state-of-the-art combination of technology and analytics. NutraNomics is much more diversified and market ready for the right customer with the right products. This new identity rounded us out with investments in IT architecture, customer relations, centralization in manufacturing and control points that have tools built for expanding market share and profits. In addition, with our diversified but laser focus characterization, we have on-boarded physicians and formulators who are experts in their fields which allows us to be a "one stop shop" controlling all the endpoints of the process and always evolving. This resurgence of who we are is the right connection to a growing market. This revitalization is built for longevity. We have never been poised and positioned better for the right alliances and acquisitions. The organization today has taken the position of being the central point partner and provider of services and products that are crucial in the fight against diseases. 

We have proven to be a pioneer in formulation, production, and commercialization of proprietary nutritional and medical supplements designed to improve customers’ health and longevity. We focus on advanced acute clinical support and alternative medicine for both short and long term use in any age group. By working with practitioners, high-end physicians, a collective of nutritional scientists, and chief nutraceutical formulators, we are able to produce cutting edge developments within both the nutraceutical and health and wellness fields. With the company’s proprietary formulations and methodologies having attracted the attention of the market from customers to the international wellness community, we are able to leverage our global expertise and connect commerce to meet the growing demand for products and services. 

Because of our developments in global marketing strategies and centralization of the manufacturing process, NutraNomics has created a strong network of global raw producers, distributors, and technology partners to meet those growing demands. Essentially, our company has evolved to become a one-stop-shop for nutraceutical needs. With emphasis on research and development, formulation, marketing, and manufacturing, our 360 approach to client care is constructed to confront the needs of our clients head-on while drastically simplifying the process. This investment has paid off immediately with increased sales and an operational structure that allows us to expand our profitability while growing revenues.  We are poised for continued and expansive growth. 

Safe Harbor Statement

This press release contains forward-looking statements that can be identified by terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results or implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company's control. Forward-looking statements speak only as to the date they are made and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

Contact:

Jonathan BishopCEO
NutraNomics Inc.
www.NutraNomics.com
Phone:(888) 935-0530


 

Nutranomics (CE) (USOTC:NNRX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Nutranomics (CE) Charts.
Nutranomics (CE) (USOTC:NNRX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Nutranomics (CE) Charts.